HealthCare Royalty Partners (HCR) is an investment firm that provides structured financing solutions for the life science industry. HCR provides non-dilutive capital in order to invest in commercial or near-commercial stage assets and companies. HCR also purchases royalties from companies, institutions and inventors. HCR has raised approximately $3.4 billion in committed capital and is headquartered in Stamford, CT with offices in Boston, MA and San Francisco, CA. HCR’s team, together with its Strategic Advisory Board, comprises 32 professionals, including 10 individuals with either PhDs, MDs or advanced degrees in life sciences. Since 2002, HCR's senior professionals have completed more than 60 healthcare investments. For more information, visit www.healthcareroyalty.com.